Orthostatic Hypotension in Multiple System Atrophy: Related Factors and Disease Prognosis

纯自主神经功能衰竭 直立生命体征 医学 萎缩 内科学 血压 胃肠病学 帕金森病 自主神经系统 仰卧位 心脏病学 疾病 心率
作者
Qirui Jiang,Lingyu Zhang,Junyu Lin,Qianqian Wei,Chunyu Li,Yanbing Hou,Ruwei Ou,Kuncheng Liu,Tianmi Yang,Yi Xiao,Bi Zhao,Ying Wu,Huifang Shang
出处
期刊:Journal of Parkinson's disease [IOS Press]
卷期号:13 (8): 1313-1320 被引量:7
标识
DOI:10.3233/jpd-230095
摘要

Background: Multiple system atrophy (MSA) is a rare neurodegenerative disease characterized by Parkinsonism, ataxia, and autonomic nervous failure. Orthostatic hypotension (OH) is the main feature of central vascular autonomic failure in MSA. Objective: The study aimed elucidate the effects of OH on cognitive function, disease milestones, and survival. Methods: A total of 444 patients with clinically established MSA were enrolled. Mild and severe OH were defined as a decrease in systolic blood pressure (SBP)/diastolic blood pressure (DBP) >20/10 mmHg and SBP/DBP ≥30/15 mmHg, respectively. Results: In this study, 215 MSA patients presented without OH, 88 had mild OH, and 141 had severe OH. The proportion of MSA-C in the severe OH subgroup was significantly higher than that in the subgroup without OH (95/46 vs. 113/102, p = 0.021). The UMSARS I score and the frequency of supine hypertension (SH) in patients with OH were significantly higher than those in patients without OH (16.22 vs. 16.89 vs. 14.60, p < 0.001; 77/64 vs. 29/59 vs. 32/183, p < 0.001). Factors related to the severity of OH included sex (OR, 0.65; p = 0.031), onset age (OR, 0.98; p = 0.029), and SH (OR, 0.21; p < 0.001). The median survival time of patients with severe OH was significantly lower than that of patients without OH (6.79 vs. 8.13 years, p = 0.001). Consistently, Cox survival analysis found that compared with patients without OH, patients with severe OH had a significantly increased risk of death (OR, 2.22; p < 0.001). Conclusion: Our large cohort study of MSA provides additional evidence for the negative impact of severe OH on survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yijian完成签到,获得积分10
1秒前
1秒前
冰柠檬完成签到,获得积分10
1秒前
昕昕233完成签到,获得积分20
2秒前
2秒前
du完成签到 ,获得积分0
2秒前
核桃应助朴畏采纳,获得10
2秒前
激动的金鑫完成签到,获得积分20
3秒前
生科牲完成签到,获得积分10
3秒前
3秒前
搞怪凡灵完成签到,获得积分10
4秒前
正直的广缘完成签到 ,获得积分10
4秒前
4秒前
要减肥发布了新的文献求助10
5秒前
5秒前
robo发布了新的文献求助10
6秒前
852应助cldg采纳,获得10
6秒前
wanci应助郭全虎采纳,获得10
6秒前
哈哈哈发布了新的文献求助10
6秒前
香瓜发布了新的文献求助20
6秒前
慕青应助6666666666采纳,获得10
7秒前
芋泥完成签到,获得积分10
7秒前
8秒前
小糊涂完成签到,获得积分10
9秒前
邢彬完成签到 ,获得积分10
9秒前
帅小主发布了新的文献求助10
9秒前
zhang完成签到,获得积分10
10秒前
研友_VZG7GZ应助凌会香采纳,获得10
10秒前
夏尔发布了新的文献求助10
12秒前
lnb完成签到,获得积分10
13秒前
领导范儿应助笑点低忆南采纳,获得10
14秒前
14秒前
14秒前
琉璃完成签到,获得积分10
15秒前
15秒前
小吴完成签到,获得积分20
15秒前
Liangstar完成签到 ,获得积分10
16秒前
可爱的函函应助zhuzhuzhu1024采纳,获得10
16秒前
风趣的念薇完成签到,获得积分10
16秒前
上官若男应助邓邵斌采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
줄기세포 생물학 1000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
Pediatric Injectable Drugs 500
Instant Bonding Epoxy Technology 500
ASHP Injectable Drug Information 2025 Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4402986
求助须知:如何正确求助?哪些是违规求助? 3889680
关于积分的说明 12105949
捐赠科研通 3534341
什么是DOI,文献DOI怎么找? 1939304
邀请新用户注册赠送积分活动 980109
科研通“疑难数据库(出版商)”最低求助积分说明 877107